Qube Research & Technologies (QRT)’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,421	Closed	-$8K	–	3168
2022 Q3	$8K	Sell	10,421 -863	-8%	-$1.81K	﹤0.01%	2379
2022 Q2	$32K	Buy	+11,284	New	+$39.6K	﹤0.01%	2202
2021 Q3	–	Sell	-11,584	Closed	-$215K	–	2958
2021 Q2	$215K	Buy	+11,584	New	+$222K	﹤0.01%	1756

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CDAK Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q4 2022, closing a stake of 10,421 shares — an estimated $8K sold.

Qube Research & Technologies (QRT) first reported a position in CDAK in Q2 2021 and held it in 3 quarters. The position peaked at $215K in Q2 2021. 40 funds tracked by Wall St. Rank hold CDAK as of Q4 2022.

Qube Research & Technologies (QRT) reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 10,421 Codiak BioSciences, Inc. Common Stock shares in Q4 2022, an estimated $8K.
Qube Research & Technologies (QRT) first reported a position in Codiak BioSciences, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Qube Research & Technologies (QRT)'s Codiak BioSciences, Inc. Common Stock position peaked at $215K in Q2 2021.
40 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.